Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04509622. IPD Sharing: YES. Countries: 1. Publications: 0.
Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01636609. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Using Sorafenib as a Salvage Treatment for Relapsed or Refractory Acute Myeloid Leukemia Carrying FLT3-ITD
ClinicalTrials.gov study NCT03622541. IPD Sharing: NO. Countries: 1. Publications: 0.
Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03672539. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04980885. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dexamethasone Added to Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03609060. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05987696. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01723657. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01146210. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00039117. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03467386. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05603884. IPD Sharing: NO. Countries: 1. Publications: 0.
CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old
ClinicalTrials.gov study NCT04269213. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT05829226. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide In Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00839059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT06529731. IPD Sharing: NO. Countries: 1. Publications: 0.
Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75
ClinicalTrials.gov study NCT03902665. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00004918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real World Use of Azacitidine and Venetoclax in Acute Myeloid Leukemia in Frontline and Relapse/Refractory
ClinicalTrials.gov study NCT06429670. IPD Sharing: NO. Countries: 1. Publications: 0.
First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02335814. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.